Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
Main Authors: | Martina Burlando, MD, Mattia Fabio Molle, MD, Chiara Trambaiolo Antonelli, MD, Emanuele Cozzani, MD, PhD, Aurora Parodi, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620302113 |
Similar Items
-
Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report
by: Martina Burlando, et al.
Published: (2021-04-01) -
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
Treatment of recurrent erythema multiforme with adalimumab as monotherapy
by: Bryan Baillis, MD, et al.
Published: (2017-03-01) -
Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
by: Maeve Lynch, MD, MBBChBAO, et al.
Published: (2017-05-01) -
Erythema multiforme associated with Entamoeba histolytica
by: Karyn Haitz, MD, et al.
Published: (2021-01-01)